Showing results (1241-1250 of 1,535) with videos related to
Sort By:
Pageof 154
Nature Chemical Biology|February 13, 2023
Structural basis of efficacy-driven ligand selectivity at GPCRsAlexander S Powers, Vi Pham, Wessel A C Burger, et al.Nature|March 10, 2016
Crystal structures of the M1 and M4 muscarinic acetylcholine receptorsDavid M Thal, Bingfa Sun, Dan Feng, et al.BMC Cancer|January 16, 2019
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinomaHouda Bahig, Francine Aubin, John Stagg, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2024
Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally UnsuppressedMatthew D Hickey, Janet Grochowski, Francis Mayorga-Munoz, et al.Therapeutic Advances in Medical Oncology|February 22, 2021
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access programNikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, et al.Annals of Internal Medicine|July 3, 2023
Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIVMonica Gandhi, Matthew Hickey, Elizabeth Imbert, et al.American Journal of Medicine Open|July 21, 2023
The temporal relationship of alcohol use and subsequent self-reported health status among people with HIVJarratt D Pytell, Ximin Li, Carol Thompson, et al.Clinical and Translational Radiation Oncology|May 2, 2024
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factorsL Hahnemann, A Krämer, C Fink, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 3, 2015
Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesionsNagendra R Pokala, Rohan V Menon, Siddharth M Patel, et al.Cancers|November 25, 2023
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion MutationsPetros Christopoulos, Nicolas Girard, Claudia Proto, et al.Pageof 154